# Camlin Fine Sciences (NSE: CAMLINFINE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/CAMLINFINE · Pivot · prices to 22 Oct 2026

Camlin Fine Sciences (NSE: CAMLINFINE) closed at ₹85.67 on 22 Oct 2026, down 1.42% on the day. With a market capitalisation of ₹1,646 Cr, it ranks 1222nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

Its return on equity was −15.5% in FY25. Over the past year the share price has fallen 54.9%. Its 52-week range is ₹83.38 (22 Oct 2026) to ₹204.57 (23 Oct 2025); the last close is 58.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹425 Cr (−2.9% year on year) and net profit ₹85 Cr, on a consolidated basis. Promoters held 48.03% of the company as of 30 Jun 2026; 16.21% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹85.67 |
| Market cap | ₹1,646 Cr |
| ROE | −15.5% (FY25) |
| ROCE | 13.5% (FY25) |
| Debt to equity | 0.72 |
| 52-week high | ₹204.57 (23 Oct 2025) |
| 52-week low | ₹83.38 (22 Oct 2026) |
| 1-year return | −54.9% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹425 Cr | −2.9% | ₹85 Cr | — | ₹4.59 |
| Q3 FY26 | ₹457 Cr | +5.5% | −₹37 Cr | — | −₹1.91 |
| Q2 FY26 | ₹460 Cr | +8.7% | −₹15 Cr | — | −₹0.77 |
| Q1 FY26 | ₹424 Cr | +7.0% | −₹12 Cr | — | −₹0.52 |
| Q4 FY25 | ₹437 Cr | +8.9% | −₹2 Cr | — | −₹0.04 |
| Q3 FY25 | ₹433 Cr | +12.3% | −₹6 Cr | — | −₹0.24 |
| Q2 FY25 | ₹423 Cr | +4.2% | −₹117 Cr | — | −₹5.98 |
| Q1 FY25 | ₹396 Cr | −5.7% | −₹35 Cr | −388.3% | −₹2.03 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,667 Cr | −₹159 Cr |
| FY24 | ₹1,613 Cr | −₹105 Cr |
| FY23 | ₹1,682 Cr | ₹40 Cr |
| FY22 | ₹1,412 Cr | ₹61 Cr |
| FY21 | ₹1,187 Cr | ₹65 Cr |
| FY20 | ₹1,049 Cr | ₹30 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 48.03%
- Foreign institutions: 0.91%
- Domestic institutions: 5.42%
- Non-institutions: 45.64%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [GOCL Corporation](https://app.pivotnow.in/stock/GOCLCORP) | ₹343.10 | ₹1,701 Cr | 6.1 | — |
| [Vidhi Specialty Food Ingredients](https://app.pivotnow.in/stock/VIDHIING) | ₹329.20 | ₹1,644 Cr | 33.6 | — |
| [Bharat Rasayan](https://app.pivotnow.in/stock/BHARATRAS) | ₹978.00 | ₹1,626 Cr | 2.8 | — |
| [Paushak](https://app.pivotnow.in/stock/PAUSHAKLTD) | ₹658.50 | ₹1,624 Cr | 41.3 | — |
| [Insecticides (India)](https://app.pivotnow.in/stock/INSECTICID) | ₹547.10 | ₹1,592 Cr | 11.4 | — |
| [Citurgia Bioche](https://app.pivotnow.in/stock/CITURGIA) | — | ₹1,583 Cr | — | — |

## Questions and answers

### What is the share price of Camlin Fine Sciences today?

Camlin Fine Sciences (NSE: CAMLINFINE) last closed at ₹85.67 on 22 Oct 2026. Its 52-week high is ₹204.57 and its 52-week low is ₹83.38.

### What is the market cap of Camlin Fine Sciences?

Camlin Fine Sciences' market capitalisation is ₹1,646 Cr (₹1,646 Cr) at the 22 Oct 2026 close, ranking 1222nd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Camlin Fine Sciences?

Return on equity was −15.5% in FY25 and return on capital employed was 13.5% in FY25 (consolidated figures).

### Is Camlin Fine Sciences a debt-free company?

No. Camlin Fine Sciences' debt-to-equity ratio was 0.72 in FY25, with total debt of ₹268 Cr.

### What were Camlin Fine Sciences' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Camlin Fine Sciences reported revenue of ₹425 Cr, −2.9% year on year, and net profit of ₹85 Cr.

### How has Camlin Fine Sciences stock performed over the last year?

Camlin Fine Sciences' share price has fallen 54.9% over the past year, −29.4% over three months and −13.7% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Camlin Fine Sciences?

As of 30 Jun 2026: promoters 48.03%, foreign institutions 0.91%, domestic institutions 5.42%, non-institutions 45.64%. 16.21% of promoter shares were pledged.

### Who are Camlin Fine Sciences' competitors?

The listed Chemicals companies closest to Camlin Fine Sciences by market cap are GOCL Corporation, Vidhi Specialty Food Ingredients, Bharat Rasayan, Paushak, Insecticides (India) and Citurgia Bioche.

### Is Camlin Fine Sciences a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Camlin Fine Sciences' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on CAMLINFINE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.